The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-
19) booster dose vaccination after completing the primary vaccination series for …

Messenger RNA (mRNA) vaccines against COVID‐19 are the first authorized biological
preparations developed using this platform. During the pandemic, their administration has …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and
spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine …

The emerging SARS-CoV-2 variants and waning vaccine-elicited immunity are two public
health challenges that occurred simultaneously and synergistically during the summer of …

This cross-sectional study, conducted in Naples (Italy) between 16 November and 6
December 2021, explored the willingness to receive the booster dose of the COVID-19 …

SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as
COVID-19 evolves toward more transmissible varieties and serum antibody levels in …

Due to the emergence of various highly contagious variants of SARS-CoV-2, vaccine
boosters were adopted as a complementary strategy in different countries. This strategy has …

COVID-19 infections are returning to many countries because of the emergence of variants
or declining antibody levels provided by vaccines. An additional dose of vaccination is …

This was a retrospective cohort study, which aimed to investigate the factors associated with
hesitancy to receive a third dose of a coronavirus disease 2019 (COVID-19) vaccine. A …

As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines
will play an important role in personal and public health. However, convincing people to take …